Retrospective feasibility study of simultaneous integrated boost in cervical cancer using Tomotherapy: the impact of organ motion and tumor regression.

Radiat Oncol · 2013 · PMC3551799 · PMID 23286694

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

The dosimetric consequences of this target-missing might not be significant as some portions of the CTV-SIB continued to receive at least some dose, and remained well contained in the pelvis PTV.

also in 670 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.